20/05/2026 Savara presented biomarker data from the Phase 3 trial of molgramostim inhalation solution in aPAP at the ATS International Conference 2026 Savara presented biomarker data from the Phase 3 trial of molgramostim inhalation solution in aPAP at the ATS International Conference 2026 (Ref) Savara presented a poster at American Thoracic Society (ATS) International Conference 2026. The poster reported new biomarker data from the Phase 3, IMPALA-2, double blind study which